News

Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector…
Read More...

Petra Pharma Corporation announced that it has secured a global license from Takeda Pharmaceutical Company Limited to develop, manufacture and commercialize serabelisib and two…
Read More...

HemoShear Therapeutics, LLC announced an extension of its partnership with Takeda Pharmaceutical Company Limited to discover and develop additional novel therapeutics for liver…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial…
Read More...

Merck and NGM Biopharmaceuticals announced that Merck has exercised its option to extend the research phase of the companies’ broad, strategic collaboration for an additional two-year…
Read More...

Alexion Pharmaceuticals and Affibody AB announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development,…
Read More...

The Mundipharma network of independent associated companies is pleased to launch the type-2 diabetes mellitus (T2DM) treatments Invokana (canagliflozin) and Vokanamet (canagliflozin,…
Read More...

WuXi Biologics announced that it has received EMA GMP certificates for the production of Trogarzo at its cGMP Drug Substance (DS) and Drug Product (DP) manufacturing facilities in Wuxi…
Read More...

EastGate Biotech Corp., a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes,…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam),…
Read More...

Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved ZULRESSOTM (brexanolone) injection for the treatment of postpartum depression (PPD). ZULRESSO…
Read More...

TESARO, an oncology-focused business acquired by GlaxoSmithKline plc, announced the presentation of data from the Phase 1/2 GARNET study evaluating dostarlimab in women with recurrent…
Read More...

Evotec AG and The Global Antibiotic Research and Development Partnership are today announcing the formation of a new strategic public-private partnership to tackle the growing threat of…
Read More...

Ono Pharmaceutical and twoXAR announced that the companies have signed a drug discovery research collaboration to jointly discover and develop novel, efficacious treatments to address…
Read More...

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary oligonucleotide delivery technology to develop novel agents, announced that the company has entered into a…
Read More...

Novo Nordisk announced that a settlement between Novo Nordisk and Teva Pharmaceuticals USA, Inc. (Teva) has been reached on the US patent litigation case for Victoza (liraglutide).…
Read More...

Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) with the FDA and EMA. Nintedanib…
Read More...

Xeris Pharmaceuticals announced that it has now begun dosing patients in a Phase 2 trial with its ready-to-use, room-temperature stable liquid glucagon in patients with Type 1 diabetes…
Read More...

Iktos announced a collaboration agreement with Merck KGaA, Darmstadt, Germany where Iktos generative modelling artificial intelligence (AI) technology will be used to facilitate the…
Read More...

Kitov Pharma announced it has signed an agreement to acquire FameWave Ltd., a privately held biopharmaceutical company developing CM-24, a clinical stage monoclonal antibody targeting…
Read More...